MetLife Investment Management’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,257
| Closed | -$82.7K | – | 2800 |
|
|
2023
Q4 | $82.7K | Hold |
11,257
| – | – | ﹤0.01% | 2682 |
|
|
2023
Q3 | $86.5K | Hold |
11,257
| – | – | ﹤0.01% | 2650 |
|
|
2023
Q2 | $114K | Buy |
+11,257
| New | +$114K | ﹤0.01% | 2596 |
|
|
2021
Q4 | – | Sell |
-3,719
| Closed | -$98.7K | – | 2524 |
|
|
2021
Q3 | $98.7K | Buy |
+3,719
| New | +$98.7K | ﹤0.01% | 2443 |
|